Lv11
30 积分 2025-04-22 加入
Preclinical efficacy and pharmacokinetics of an RNA-encoded T cell–engaging bispecific antibody targeting human claudin 6
41分钟前
已完结
Elimination of large tumors in mice by mRNA-encoded bispecific antibodies
42分钟前
已完结
Historical Overview of Regulatory Approvals and PMDA Assessments for Biosimilar Products in Japan During 2009–2022
2个月前
已完结
CAR T cells produced in vivo to treat cardiac injury
2个月前
已完结
Antigen experience history directs distinct functional states of CD8+ CAR T cells during the antileukemia response
2个月前
已完结
BL-B01D1, a first-in-class EGFR–HER3 bispecific antibody–drug conjugate, in patients with locally advanced or metastatic solid tumours: a first-in-human, open-label, multicentre, phase 1 study
3个月前
已完结
Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes
3个月前
已完结
Claudin 18.2-targeting antibody–drug conjugate CMG901 in patients with advanced gastric or gastro-oesophageal junction cancer (KYM901): a multicentre, open-label, single-arm, phase 1 trial
3个月前
已完结
Peptibodies: Bridging the gap between peptides and antibodies
3个月前
已完结
First-in-class versus best-in-class: an update for new market dynamics
4个月前
已完结
皖公网安备34019202002308
